Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Desai, S ; Tavoschi, L ; Sullivan, A K ; Combs, L ; Raben, D ; Delpech, V ; Jakobsen, S F ; Amato-Gauci, A J ; Croxford, S. / HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA) : evidence from a systematic review. I: HIV Medicine. 2020 ; Bind 21, Nr. 3. s. 163-179.

Bibtex

@article{a1c616b495204bfc9cc816e2fccec10d,
title = "HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review",
abstract = "OBJECTIVES: Despite the availability of HIV testing guidelines to facilitate prompt diagnosis, late HIV diagnosis remains high across Europe. The study synthesizes recent evidence on HIV testing strategies adopted in health care settings in the European Union/European Economic Area (EU/EEA).METHODS: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed and systematic searches were run in five databases (2010-2017) to identify studies describing HIV testing interventions in health care settings in the EU/EEA. The grey literature was searched for unpublished studies (2014-2017). Two reviewers independently performed study selection, data extraction and critical appraisal.RESULTS: One hundred and thirty intervention and/or feasibility studies on HIV testing in health care settings were identified. Interventions included testing provision (n = 94), campaigns (n = 14) and education and training for staff and patients (n = 20). HIV test coverage achieved through testing provision varied: 2.9-94{\%} in primary care compared to 3.9-66{\%} in emergency departments. HIV test positivity was lower in emergency departments (0-1.3{\%}) and antenatal services (0-0.05{\%}) than in other hospital departments (e.g. inpatients: 0-5.3{\%}). Indicator condition testing programmes increased HIV test coverage from 3.9-72{\%} before to 12-85{\%} after their implementation, with most studies reporting a 10-20{\%} increase. There were 51 feasibility and/or acceptability studies that demonstrated that HIV testing interventions were generally acceptable to patients and providers in health care settings (e.g. general practitioner testing acceptable: 77-93{\%}).CONCLUSIONS: This review has identified several strategies that could be adopted to achieve high HIV testing coverage across a variety of health care settings and populations in the EU/EEA. Very few studies compared the intervention under investigation to a baseline, but, where this was assessed, data suggested increases in testing.",
keywords = "adults, Europe, health care, HIV diagnosis and adults, HIV testing",
author = "S Desai and L Tavoschi and Sullivan, {A K} and L Combs and D Raben and V Delpech and Jakobsen, {S F} and Amato-Gauci, {A J} and S Croxford",
note = "{\circledC} 2019 The Authors. HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association.",
year = "2020",
month = "3",
doi = "10.1111/hiv.12809",
language = "English",
volume = "21",
pages = "163--179",
journal = "HIV Medicine",
issn = "1464-2662",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "3",

}

RIS

TY - JOUR

T1 - HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA)

T2 - evidence from a systematic review

AU - Desai, S

AU - Tavoschi, L

AU - Sullivan, A K

AU - Combs, L

AU - Raben, D

AU - Delpech, V

AU - Jakobsen, S F

AU - Amato-Gauci, A J

AU - Croxford, S

N1 - © 2019 The Authors. HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association.

PY - 2020/3

Y1 - 2020/3

N2 - OBJECTIVES: Despite the availability of HIV testing guidelines to facilitate prompt diagnosis, late HIV diagnosis remains high across Europe. The study synthesizes recent evidence on HIV testing strategies adopted in health care settings in the European Union/European Economic Area (EU/EEA).METHODS: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed and systematic searches were run in five databases (2010-2017) to identify studies describing HIV testing interventions in health care settings in the EU/EEA. The grey literature was searched for unpublished studies (2014-2017). Two reviewers independently performed study selection, data extraction and critical appraisal.RESULTS: One hundred and thirty intervention and/or feasibility studies on HIV testing in health care settings were identified. Interventions included testing provision (n = 94), campaigns (n = 14) and education and training for staff and patients (n = 20). HIV test coverage achieved through testing provision varied: 2.9-94% in primary care compared to 3.9-66% in emergency departments. HIV test positivity was lower in emergency departments (0-1.3%) and antenatal services (0-0.05%) than in other hospital departments (e.g. inpatients: 0-5.3%). Indicator condition testing programmes increased HIV test coverage from 3.9-72% before to 12-85% after their implementation, with most studies reporting a 10-20% increase. There were 51 feasibility and/or acceptability studies that demonstrated that HIV testing interventions were generally acceptable to patients and providers in health care settings (e.g. general practitioner testing acceptable: 77-93%).CONCLUSIONS: This review has identified several strategies that could be adopted to achieve high HIV testing coverage across a variety of health care settings and populations in the EU/EEA. Very few studies compared the intervention under investigation to a baseline, but, where this was assessed, data suggested increases in testing.

AB - OBJECTIVES: Despite the availability of HIV testing guidelines to facilitate prompt diagnosis, late HIV diagnosis remains high across Europe. The study synthesizes recent evidence on HIV testing strategies adopted in health care settings in the European Union/European Economic Area (EU/EEA).METHODS: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed and systematic searches were run in five databases (2010-2017) to identify studies describing HIV testing interventions in health care settings in the EU/EEA. The grey literature was searched for unpublished studies (2014-2017). Two reviewers independently performed study selection, data extraction and critical appraisal.RESULTS: One hundred and thirty intervention and/or feasibility studies on HIV testing in health care settings were identified. Interventions included testing provision (n = 94), campaigns (n = 14) and education and training for staff and patients (n = 20). HIV test coverage achieved through testing provision varied: 2.9-94% in primary care compared to 3.9-66% in emergency departments. HIV test positivity was lower in emergency departments (0-1.3%) and antenatal services (0-0.05%) than in other hospital departments (e.g. inpatients: 0-5.3%). Indicator condition testing programmes increased HIV test coverage from 3.9-72% before to 12-85% after their implementation, with most studies reporting a 10-20% increase. There were 51 feasibility and/or acceptability studies that demonstrated that HIV testing interventions were generally acceptable to patients and providers in health care settings (e.g. general practitioner testing acceptable: 77-93%).CONCLUSIONS: This review has identified several strategies that could be adopted to achieve high HIV testing coverage across a variety of health care settings and populations in the EU/EEA. Very few studies compared the intervention under investigation to a baseline, but, where this was assessed, data suggested increases in testing.

KW - adults

KW - Europe

KW - health care

KW - HIV diagnosis and adults

KW - HIV testing

U2 - 10.1111/hiv.12809

DO - 10.1111/hiv.12809

M3 - Journal article

VL - 21

SP - 163

EP - 179

JO - HIV Medicine

JF - HIV Medicine

SN - 1464-2662

IS - 3

ER -

ID: 58628378